Tweet
Lilly to End Development of Lupus Drug on Trial Failure Businessweek Eli Lilly & Co. (LLY:US) will end development of an experimental drug for lupus after the medicine failed to help patients in two late-stage clinical trials. The treatment, tabalumab, didn't produce a statistically significant improvement for patients taking either of ... Eli Lilly to drop development of lupus drugReuters Eli Lilly to Stop Development of Tabalumab for LupusWall Street Journal Eli Lilly scraps tabalumab for lupus after it flops in (another) PhIII programFierceBiotech NASDAQ -DigitalJournal.com all 7 news articles » |
More...